Contact
Please use this form to send email to PR contact of this press release:
Institute for Integrative Therapies Selected as a Clinical Trial Site for Cybin’s EMBRACE and EXTEND Psilocin Studies
TO:
Andrea Doss
Institute for Integrative Therapies